Search scope:
排序: Display mode:
A tentative theory of human meridian
Tang Xiaowei,Shen Xiaolei,He Hongjian
Strategic Study of CAE 2008, Volume 10, Issue 11, Pages 14-17
Keywords: human meridian acupunture point neuroendocrine immune system complex networks
Mechanisms of “kidney governing bones” theory in traditional Chinese medicine
Dahong Ju,Meijie Liu,Hongyan Zhao,Jun Wang
Frontiers of Medicine 2014, Volume 8, Issue 3, Pages 389-393 doi: 10.1007/s11684-014-0362-y
Keywords: kidney governing bones kidney deficiency marrow osteoporosis neuroendocrine-immune network osteoclast
Frontiers of Medicine Pages 907-923 doi: 10.1007/s11684-023-1009-7
Keywords: FAK6/7 SRRM4 neuroendocrine neoplasms pancreas breast
Xinghua Gao, Hongduo Chen
Frontiers of Medicine 2014, Volume 8, Issue 1, Pages 1-5 doi: 10.1007/s11684-014-0309-3
Keywords: hyperthermia HPV immune response virus tumor
An Immune Agent-based Performance Rejuvenation for Grid
Xu Jian,Zhang Kun, Liu Fengyu
Strategic Study of CAE 2007, Volume 9, Issue 11, Pages 87-91
Simulating biological immune mechanism to implement performance rejuvenation This paper analyzes and compares the immune process's characteristics and computing system's rejuvenation, sets up the logical model of system rejuvenation based on immune agent abovesimulates the biological immune mechanisms to monitor resource usage and diagnose performance degradation On the basis of above an application regarding audio-video resource transaction process system
Keywords: grid immune system performance monitoring software rejuvenation immune agent
A case of primary neuroendocrine breast carcinoma that responded to neo-adjuvant chemotherapy
Xiaolong Wei,Chunfa Chen,Didi Xi,Jinwen Bai,Wenhe Huang,Luoxiang Rong,Mingyao Wu,Guojun Zhang
Frontiers of Medicine 2015, Volume 9, Issue 1, Pages 112-116 doi: 10.1007/s11684-014-0345-z
Primary neuroendocrine breast carcinoma (NEBC) is a very rare type of breast cancer.
Keywords: neuroendocrine carcinoma neo-adjuvant therapy breast
Yugang Cheng,Hanxiang Zhan,Lei Wang,Jianwei Xu,Guangyong Zhang,Zongli Zhang,Sanyuan Hu
Frontiers of Medicine 2016, Volume 10, Issue 4, Pages 444-450 doi: 10.1007/s11684-016-0471-x
The incidence rate of pancreatic neuroendocrine neoplasms (pNENs) has increased rapidly in recent
Keywords: pancreatic neuroendocrine neoplasms clinicopathological characteristic Ki-67 liver metastasis outcomes
Advances on immune-related adverse events associated with immune checkpoint inhibitors
Yong Fan, Yan Geng, Lin Shen, Zhuoli Zhang
Frontiers of Medicine 2021, Volume 15, Issue 1, Pages 33-42 doi: 10.1007/s11684-019-0735-3
Keywords: cancer immunotherapy immune checkpoint inhibitors immune-related adverse events review
Natural killer cells in liver diseases
Meijuan Zheng, Haoyu Sun, Zhigang Tian
Frontiers of Medicine 2018, Volume 12, Issue 3, Pages 269-279 doi: 10.1007/s11684-018-0621-4
Keywords: natural killer cell phenotype immune activation immune tolerance liver diseases
Tangchun Wu
Frontiers of Medicine 2020, Volume 14, Issue 6, Pages 816-819 doi: 10.1007/s11684-020-0823-4
Heterogeneity of the tumor immune microenvironment and clinical interventions
Frontiers of Medicine 2023, Volume 17, Issue 4, Pages 617-648 doi: 10.1007/s11684-023-1015-9
Keywords: Heterogeneity tumor immune
Molecular classification and precision therapy of cancer: immune checkpoint inhibitors
Yingyan Yu
Frontiers of Medicine 2018, Volume 12, Issue 2, Pages 229-235 doi: 10.1007/s11684-017-0581-0
Keywords: molecular classification precision medicine pembrolizumab PD-1/PD-L1 MSI-H
SARS-CoV-2 variants, immune escape, and countermeasures
Frontiers of Medicine 2022, Volume 16, Issue 2, Pages 196-207 doi: 10.1007/s11684-021-0906-x
Keywords: SARS-CoV-2 COVID-19 vaccine immune escape breakthrough prevention
Multi-target combinatory strategy to overcome tumor immune escape
Frontiers of Medicine 2022, Volume 16, Issue 2, Pages 208-215 doi: 10.1007/s11684-022-0922-5
Keywords: immune checkpoints multi-target immune escape immune-related adverse events combination therapy
Frontiers of Medicine 2022, Volume 16, Issue 5, Pages 773-783 doi: 10.1007/s11684-021-0902-1
Keywords: benefit China eligibility immune checkpoint inhibitor public health
Title Author Date Type Operation
Mechanisms of “kidney governing bones” theory in traditional Chinese medicine
Dahong Ju,Meijie Liu,Hongyan Zhao,Jun Wang
Journal Article
High frequency of alternative splicing variants of the oncogene in neuroendocrine tumors of the pancreas
Journal Article
Hyperthermia on skin immune system and its application in the treatment of human papillomavirus-infected
Xinghua Gao, Hongduo Chen
Journal Article
An Immune Agent-based Performance Rejuvenation for Grid
Xu Jian,Zhang Kun, Liu Fengyu
Journal Article
A case of primary neuroendocrine breast carcinoma that responded to neo-adjuvant chemotherapy
Xiaolong Wei,Chunfa Chen,Didi Xi,Jinwen Bai,Wenhe Huang,Luoxiang Rong,Mingyao Wu,Guojun Zhang
Journal Article
Analysis of 100 consecutive cases of resectable pancreatic neuroendocrine neoplasms: clinicopathological
Yugang Cheng,Hanxiang Zhan,Lei Wang,Jianwei Xu,Guangyong Zhang,Zongli Zhang,Sanyuan Hu
Journal Article
Advances on immune-related adverse events associated with immune checkpoint inhibitors
Yong Fan, Yan Geng, Lin Shen, Zhuoli Zhang
Journal Article
Persistence of humoral and cellular immune response after SARS-CoV-2 infection: opportunities and challenges
Tangchun Wu
Journal Article
Molecular classification and precision therapy of cancer: immune checkpoint inhibitors
Yingyan Yu
Journal Article